"A single vaccine will provide lifelong protection against various types of diseases and cancers caused by HPV," stated Health Minister Nísia Trindade.
Since 2009, researchers at Brazil’s Butantan Institute have been studying the production of a new dengue vaccine. The inoculation is currently in its final phase of clinical trials.
The jab can be administered to people aged 12 and over. It is the sixth inoculation to receive definitive registration.
By joining a United Nations network, the Brazilian lab will supply vaccines to other countries, especially in Latin America, during epidemics or pandemics.
In 2019, Brazil lost its measles elimination certificate, primarily due to a decrease in demand for the vaccine against the disease, as stated by the minister.
Português 
Español 
